Credit Analysis: GLENTHAM LIFE SCIENCES LIMITED

1. Credit Opinion: CONDITIONAL

Reasoning: The company demonstrates strong profitability and growth in FY2025, with net assets nearly doubling to £1.33M and retained earnings increasing by approximately £721k. However, the significant intercompany balance (£1.94M owed to group undertakings) creates material uncertainty regarding the true nature of obligations and cash flow priorities within the wider group structure. Credit approval is recommended subject to satisfactory clarification of group arrangements and appropriate structural protections.

The company's fundamental trading position appears sound — corporation tax liability increasing from £320k to £549k independently validates strong profit generation — but the intercompany position warrants further scrutiny before unconditionally committing facilities.

2. Financial Strength

Balance Sheet Summary (FY2025 vs FY2024):

Positive Indicators: - Strong capital accumulation through retained profits rather than share issuance - Net assets have recovered substantially from the FY2023-2024 dip, exceeding pre-dip levels - No indication of dividend stripping — profits being retained within the business - Modest long-term bank debt (£70,750) being steadily repaid

Concerning Elements: - Share capital remains at £100 — minimal equity cushion from shareholders directly - The intercompany balance (£1.94M) represents 72% of current liabilities and raises questions about group financing arrangements and whether this debt could be called upon in stress scenarios - Net assets remain below the FY2020-2021 peak of £1.85M, suggesting the business has taken on additional obligations

Asset Quality: - Fixed assets are predominantly leasehold property (£397,825) with plant & machinery (£134,174) — appropriate for a chemical wholesaler - Stock levels of £1.68M are significant (46% of current assets) and have increased 26% year-on-year — potential obsolescence risk given the nature of chemical products - Debtors increased 53% to £1.25M — requires assessment of collectibility and debtor days

3. Cash Flow Assessment

Liquidity Position:

Cash Flow Observations: - Cash increased 63% from £402k to £657k, indicating genuine cash generation - Working capital position improved significantly (from £225k to £996k) - However, excluding the intercompany debt from current liabilities would show a current ratio of approximately 8.5:1 — the classification and terms of this debt are critical

Working Capital Concerns: - Trade debtors grew by £574k (85% increase) — significantly outpacing revenue growth indicators, suggesting potential collection issues or extended credit terms to customers - Stock increased by £347k (26%) — while possibly supporting revenue growth, chemical inventory carries obsolescence and handling risks - Trade creditors only increased by £71k (56%) — the company is not significantly extending supplier payment terms to fund growth

Debt Service Capacity: - Long-term bank loans are modest (£70,750) and declining - Corporation tax liability of £549k is payable within one year — this is a non-discretionary obligation requiring adequate cash reserves - No evidence of external bank borrowing beyond the modest long-term loan

4. Monitoring Points

Priority 1 — Immediate Clarification Required: 1. Intercompany Debt Terms: Obtain confirmation of the nature, repayment terms, and subordination status of the £1.94M owed to group undertakings. Determine if this is callable on demand and whether any intercreditor agreements exist 2. Group Structure: Map the wider group structure to understand cash flow dependencies, cross-guarantees, and the financial health of the parent/sister entities

Priority 2 — Ongoing Monitoring: 3. Debtor Quality: Monitor trade debtor days and aging. The 53% increase in debtors warrants investigation — obtain debtor aging analysis and assess provision adequacy 4. Stock Management: Track stock turnover ratios. Chemical products can become obsolete; the 26% increase in stock levels should be assessed against revenue growth 5. Profitability Sustainability: Request profit & loss account detail to understand margins, overhead trends, and the drivers behind the strong FY2025 performance 6. Employee Costs: Headcount increased from 29 to 35 (21%) — monitor whether revenue growth is keeping pace with the expanded cost base

Priority 3 — Structural Considerations: 7. Covenant Structure: If facilities are approved, consider requiring group guarantees or charges over group assets given the intercompany exposure 8. Change of Control: Include provisions addressing any restructuring of the group or transfer of intercompany debt

Additional Context

Business Profile: - Established chemical wholesaler (since 2013) serving the life sciences sector - Supplies fine chemicals, biochemicals, APIs, and research products - Operating from Corsham, Wiltshire with 35 employees - Sector benefits from relatively defensive demand characteristics (research, diagnostics)

Management Assessment: - Three directors with complementary roles and significant personal shareholdings (two PSCs each holding 25-50%) - Accounts filed on time and to Full Exemption standard - No director disqualifications identified - The presence of a third director (Clive Hayler) not listed as a PSC suggests either a smaller shareholding or a more recent appointment — worth clarifying